MedPath
TGA Approval

RUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vial (330536)

330536

RUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vial

Pfizer Australia Pty Ltd

March 3, 2021

Medicine

Medicine

Active

Registered

Active Ingredients

rituximab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.